North China Pharmaceutical Company.Ltd (SHSE: 600812)
Health Care · Pharmaceuticals · CN
CN¥4.98
+2.05% today · -16.2% 1Y
North China Pharmaceutical Company.Ltd (SHSE: 600812) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.27B and employs 9,972 people.
Over the last twelve months the share price has lost 16.2%, trading between 4.11 and 6.29.
Tweenvest scores North China Pharmaceutical Company.Ltd across four factors: quality 59/100, value 38/100, growth 3/100, dividend 12/100. Its strongest factor is quality.
600812 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.27B
- Revenue (TTM)
- $1.21B
- P/E
- 69.25
- EPS
- 0.07
- Dividend yield
- 0.70%
- Beta (5Y)
- 0.20
- 52-week high
- CN¥6.29
- 52-week low
- CN¥4.11
- Avg volume (3M)
- —
- Shares outstanding
- 1.72B
- Employees
- 9,972
- Next earnings
- —
About North China Pharmaceutical Company.Ltd
North China Pharmaceutical Company Ltd. is a Chinese firm specializing in the chemical pharmaceutical sector. Its extensive product range primarily features anti-infective medications, supplied as active pharmaceutical ingredients (APIs), their intermediates, and final preparations. The company's offerings further encompass biotechnological therapeutics, drugs for cardiovascular conditions, immunomodulators, vitamin-based consumer health products, and specialized pharmaceuticals for agricultural and veterinary applications. Founded in 1953, North China Pharmaceutical Company Ltd. maintains its headquarters in Shijiazhuang, China.
- ISIN
- CNE000000D16
- Founded
- 1992
- Listed since
- Jan 14, 1994
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Société de Therapeutique Marocaine S.A.CBSE: SOT | $1.35B | MAD350.00 | +2.94% |
| Chengdu Easton Biopharmaceuticals Co., Ltd.SHSE: 688513 | $1.32B | CN¥51.16 | +2.32% |
| CORONA Remedies LimitedNSEI: CORONA | $1.29B | Rs2,029.40 | -4.17% |
| Celltrion Pharm, Inc.KOSDAQ: A068760 | $1.28B | ₩38,800.00 | -3.24% |
| Zhejiang Garden Biopharmaceutical Co.,Ltd.SZSE: 300401 | $1.25B | CN¥15.41 | -3.45% |
| Zhejiang Xianju Pharmaceutical Co., Ltd.SZSE: 002332 | $1.25B | CN¥8.64 | +0.35% |
| Shandong Xinhua Pharmaceutical Company LimitedSEHK: 719 | $1.24B | HK$5.80 | +0.52% |
| Jiangsu Yahong Meditech Co., Ltd.SHSE: 688176 | $1.23B | CN¥14.60 | -0.88% |
Figures last refreshed Oct 4, 2026.